Maria Queralt Salas, MD^1*, Raquel Salinas González, MD^2*, Carla Mestre^3*, Laia Guardia^4*, Cristina Moreno^5*, Berta Sole^6*, Filipe Pinto, MD^4*, Paola Charry, MD^7*, Joan Cid, MD PhD^8*, Miquel Lozano, MD, PhD^9*, Enric Cascos, MD^10*, Julia Martinez-Sanchez, PhD^11*, Maribel Diaz-Ricart, PhD^11*, Raquel Sebio^2*, Sara Laxe, MD^12*, Enric Carreras, MD, PhD^13*, Jordi Esteve, MD, PhD¹⁴, Maria Suarez-Lledo, MD, PhD^15*, Laura Rosiñol Dachs, MD PhD^16*, Concepción Closa, MD^12*, Maria Carmen Martinez Munoz, MD, PhD^5*, Francesc Fernández-Avilés, MD, PhD^17* and Montserrat Rovira, MD, PhD^17*

¹Hematopoietic Transplantation Unit, Hospital Clinic de Barcelona, ICAMS, Barcelona, Spain
²Physical Medicine and Rehabilitation Department, Hospital Clinic de Barcelona, Barcelona, Spain
³Endocrinology and Nutrition Department, Hospital Clinic of Barcelona, Barcelona, Spain
⁴Hematopoietic Transplantation Unit, Hematology Department, Clinical Institute of Hematology and Oncology (ICMHO), Hospital Clinic de Barcelona, Barcelona, Spain
⁵Hematopoietic Cell Transplant Unit, Hospital Clinic of Barcelona, ICAMS, Barcelona, Spain
⁶Hematopoietic Cell Transplant Unit, Hospital Clinic de Barcelona, ICAMS, Barcelona, Spain
⁷Apheresis and Cellular Therapy Unit, Hemotherapy and Hemostasis Department, Clinical Institute of Hematology and Oncology (ICMHO), Hospital Clinic de Barcelona, Barcelona, Spain
⁸Hospital Clinic, University of Barcelona, Barcelona, Spain
⁹Apheresis and Cellular Therapy Unit, Hemotherapy and Hemostasis Department, Clinical Institute of Hematology and Oncology (ICMHO), Hospital Clínic de Barcelona, Barcelona, Spain
¹⁰Cardiology Department, Hospital Clinic de Barcelona, Barcelona, Spain
¹¹Hemostasis and Erythropathology, Hematopathology, Pathology Department, CDB, IDIBAPS, University of Barcelona, Hospital Clínic de Barcelona, Barcelona, Spain
¹²Physical Medicine and Rehabilitation Department, Hospital Clinic of Barcelona, Barcelona, Spain
¹³Fundació Josep Carreras Contra la Leucèmia, Barcelona, Spain
¹⁴Hematology Department, Hospital Clínic Barcelona, ICAMS, Barcelona, Spain
¹⁵Hematopoietic Transplantation Unit, Hematology Department, Clinical Institute of Hematology and Oncology (ICMHO), Spain, Hospital Clínic de Barcelona, Barcelona, Spain
¹⁶Hematopoietic Cell Transplant Unit, Hospital Clínic de Barcelona, ICAMS, Barcelona, Spain
¹⁷Hematopoietic Transplantation Unit, Hematology Department, Clinical Institute of Hematology and Oncology (ICMHO), Hospital Clínic de Barcelona, Barcelona, Spain

Abdulrahman Alhajahjeh^1*, Kishan Patel, MD^2*, Rory M. Shallis, MD^3,4, Nikolai A. Podoltsev, MD, PhD^3,5, Tariq Kewan, MD⁶, Jessica M. Stempel, MD⁶, Lourdes Mendez^7*, Scott F Huntington^8,9, Maximilian Stahl, MD¹⁰, Amer M. Zeidan, MBBS, MHS^3,11, George Goshua, MD, MSc^12,13 and Jan Philipp Bewersdorf, MD^3,11

¹The Univeristy of Jordan, School of Medicine, Amman, Jordan
²Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA, New York, NY
³Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale University, New Haven, CT
⁴Department of Internal Medicine, Section of Hematology, Yale School of Medicine - Yale Cancer Center, Killingworth, CT
⁵Department of Internal Medicine, Section of Hematology, Yale University School of Medicine and Yale Cancer Center, Madison, CT
⁶Department of Internal Medicine, Section of Hematology, Yale University, New Haven, CT
⁷Department of Internal Medicine, Section of Hematology, Yale University, New Haven
⁸Yale School of Medicine, Smilow Cancer Hospital at Yale New Haven, New Haven, CT
⁹Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale School of Medicine, New Haven, CT
¹⁰Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
¹¹Department of Internal Medicine, Section of Hematology, Yale School of Medicine - Yale Cancer Center, New Haven, CT
¹²Hematology-Oncology & Yale CORE, Yale School of Medicine & Yale Cancer Center, New Haven, CT
¹³Center for Outcomes Research and Evaluation, Yale University and Yale New Haven Hospital, New Haven, CT

Allyson Waller, PharmD, BCOP^1*, Justin Tossey, PharmD, BCOP^1*, Lexus Frazier, PharmD, BCOP^1*, Pooja Kumar, PharmD, BCOP^1*, Tracelyn Freeman, PharmD, BCOP^1*, Megan Fleming, PharmD, BCOP^1*, Stephanie James^2* and Alice Mims, MD³

¹Department of Pharmacy, The James Cancer Hospital and Solove Research Institute at The Ohio State University, Columbus, OH
²Department of Pharmacy - Medication Access, The Ohio State University Wexner Medical Center, Columbus, OH
³Division of Hematology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH

Amin T. Turki, MD^1,2*, Alberto Hernández Sánchez, MD^3*, Wellington Silva⁴, Magdalena Karasek, MD^5*, Luca Guarnera, MD⁶, Koray Yalçin, MD^7*, Amir Enshaei^8*, Marta Sobas, MD^9*, Dirk Reinhardt, MD¹⁰, Maria M Rivas, MD^11*, Deepak Kumar Mishra, MD^12*, Eduardo Rego^13*, Ahmet Koc^14*, Paola Núñez Medina^15*, Maria Teresa Voso, MD¹⁶, Anthony Moorman^17*, Felix Nensa, MD^18* and Merlin Engelke^19*

¹Institute for Artificial Intelligence in Medicine, University Hospital Essen, Essen, Germany
²Department of Hematology and Oncology, Marienhospital, Ruhr-University Bochum, Bochum, Germany
³Hematology Department, Hospital Universitario de Salamanca (CAUSA/IBSAL), Salamanca, Spain
⁴University of Sao Paulo, Faculdade De Medicina USP, Sao Paulo, BRA
⁵Department of Hematology, Blood Neoplasms and Bone Marrow Transplantation, Wroclaw Medical University, Wroclaw, Poland
⁶Tor Vergata University, Rome, Italy
⁷Bahcesehir University Medical Park Göztepe Hospital, Istanbul, Turkey, Istanbul, Turkey
⁸Wolfson Childhood Cancer Research Centre, Newcastle University, Newcastle, United Kingdom
⁹Department of Hematology, Blood Neoplasms and Bone Marrow Transplantation, Medical University of Wroclaw, Wroclaw, Poland
¹⁰University Children’s Hospital Essen. Department of Pediatric Hematology and Oncology, Essen, Germany
¹¹Hospital Universitario Austral, Buenos Aires, Argentina
¹²Laboratory Hematology, Cytogenetics & Molecular Pathology, Tata Medical Center, Kolkata, West Bengal, IND
¹³Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo, Sao Paulo, Brazil
¹⁴Department of Pediatric Hematology and Oncology, Marmara University Faculty of Medicine, Istanbul, Turkey
¹⁵Department of Hematology, University of Salamanca, Salamanca, Spain
¹⁶Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy
¹⁷Leukaemia Research Cytogenetics Group, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom
¹⁸Institute for AI in Medicine, University Hospital Essen, Essen, Germany
¹⁹Department of AI in Medicine, University Hospital Essen, Essen, DEU

Natalie Pham, MD^1*, Jeffrey Lantz Jr., DO², Caroline Jones, PharmD^3*, Debamita Kundu, PhD^4*, Nicholas McCann^5*, Firas El Chaer, MD^6*, Daniel R Reed, MD² and Michael Keng, MD²

¹Department of Medicine, University of Virginia Medical Center, Charlottesville, VA
²Department of Medicine, Division of Hematology and Oncology, University of Virginia Medical Center Comprehensive Cancer Center, Charlottesville, VA
³Department of Pharmacy, University of Virginia Medical Center, Charlottesville, VA
⁴Division of Biostatistics, University of Virginia, Charlottesville, VA
⁵University of Virginia School of Medicine, Charlottesville, VA
⁶University of Virginia Health System, Charlottesville, VA

Hari S. Raman, MD¹, Scott Greenwald, PhD^2*, Edo Banach, JD^3*, Gregory A Abel, MD, MPH¹, Charlotta Lindvall, MD, PhD^4* and Oreofe O. Odejide, MD¹

¹Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
²Health Data Analytics Institute, Dedham, MA
³Manatt Health, Washington DC
⁴Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Boston, MA